ANDEXO Trademark

Trademark Overview


On Tuesday, February 27, 2024, a trademark application was filed for ANDEXO with the United States Patent and Trademark Office. The USPTO has given the ANDEXO trademark a serial number of 98423099. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, July 25, 2024. This trademark is owned by NAQVI EMPORIUM LLC. The ANDEXO trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements; Vitamins
andexo

General Information


Serial Number98423099
Word MarkANDEXO
Filing DateTuesday, February 27, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, July 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Goods and ServicesDietary and nutritional supplements; Vitamins

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 27, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNAQVI EMPORIUM LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMount Sinai, NY 11766

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 27, 2024NEW APPLICATION ENTERED
Thursday, July 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 25, 2024ASSIGNED TO EXAMINER
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED